[HTML][HTML] Serum β2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity?

W Conca, M Alabdely, F Albaiz, MW Foster, M Alamri… - PLoS …, 2021 - journals.plos.org
β 2 -microglobulin (β 2 -m), a 11.8 kDa protein, pairs non-covalently with the α3 domain of
the major histocompatibility class (MHC) I α-chain and is essential for the conformation of the …

Clinical manifestations and treatment outcomes of human brucellosis at a tertiary care center in Saudi Arabia

…, NS Alfagyh, AS Alnaghmush, F Albaiz… - Annals of Saudi …, 2021 - annsaudimed.net
BACKGROUND: Brucellosis, which has profound public health and economic consequences,
is endemic to Saudi Arabia. Brucella is transmitted to humans by direct contact with …

Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort study

FA Albaiz, KJ Ramos, J Sykes, S Stanojevic… - Liver …, 2024 - journals.lww.com
There is paucity of literature on the health outcomes following liver transplantation (LT) in
people with cystic fibrosis (pwCF). We aim to evaluate changes in lung function following LT in …

[HTML][HTML] Descriptive analysis of clinical and laboratory findings in relation to changes in SARS-CoV-2 viral dynamics and cyclic threshold: a retrospective, single center …

MM Alamri, EB Devol, AB Al-Otaibi, FA Albaiz… - …, 2022 - f1000research.com
Background: Cases of undiagnosed pneumonia have emerged, and sequencing of respiratory
samples indicated the presence of SARS-CoV-2 causing COVID-19. Patients with higher …

[PDF][PDF] Role of Fluorodeoxyglucose Positron Emission Tomogram Scan in Sirolimus-Induced Lung Toxicity: A Rare Case Report

S Saleemi, B Alothman, F Albaiz… - Experimental and …, 2020 - researchgate.net
Lung toxicity is a rare but serious side effect of sirolimus, a mammalian target of rapamycin
inhibitor used as an immunosuppressive agent in solid-organ transplant recipients. We report …

Time to negative PCR from symptom onset in COVID-19 patients on Hydroxychloroquine and Azithromycin-A real-world experience

S Saleemi, A Alrajhi, M Alhajji, A Alfattani, F Albaiz - MedRxiv, 2020 - medrxiv.org
Background The role of hydroxychloroquine (HCQ) and azithromycin in the treatment of
COVID-19 and its effect on SARS-CoV-2 viral clearance is not known. Methods This is a …

[PDF][PDF] Radiology Features of Chest Imaging and Its Correlation to Clinical Severity in Patients with COVID-19

S Saleemi, F Skaff, F Albaiz, R Almaghrabi, F Alrabiah… - Cough, 2020 - researchgate.net
Background: COVID-19 caused by SARS CoV-2 involves respiratory system leading to
respiratory failure and Acute Respiratory Distress Syndrome (ARDS) in critical patients. Several …

Time to negative PCR from symptom onset in COVID-19 patients on Hydroxychloroquine and Azithromycin-A real world experience (preprint)

SA Saleemi, A Alrajhi, M Alhajji, A Alfattani, F Albaiz - 2020 - pesquisa.bvsalud.org
Background: The role of hydroxychloroquine (HCQ) and azithromycin in the treatment of
COVID-19 and its effect on SARS-CoV-2 viral clearance is not known. Methods: This is a …

[PDF][PDF] Clinical characteristics of patients with COVID-19 in Saudi Arabia-a single center experience

S Saleemi, M Alhajji, R Almaghrabi - Res Rev Infect Dis, 2020 - researchgate.net
… 1Secfion of Pulmonary Medicine, Department of Medicine, King Faisal Specialist Hospital
& Research Center, … Faisal Albaiz: Acquisition of data or analysis and interpretation of data. …

[HTML][HTML] Safety and efficacy of convalescent plasma for severe COVID-19: interim report of a multicenter phase II study from Saudi Arabia

N AlShehry, SZA Zaidi, A AlAskar… - Saudi Journal of …, 2021 - journals.lww.com
Objective: To present the interim findings from a national study investigating the safety and
efficacy of convalescent plasma (CP) containing detectable IgG antibodies as a treatment …